Company
Headquarters: Fuzhou, China
Employees: 708
CN¥4.04 Billion
CNY as of Jan. 1, 2024
US$568.9 Million
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers Chinese patent medicines in the areas of liver diseases, andrology, cardiovascular, and other fields. The company was founded in 2001 and is based in Fuzhou, China.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Fujian Cosunter Pharmaceutical Co. Ltd has the following listings and related stock indices.
Stock: SZSE: 300436 wb_incandescent